This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated DUSP4 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-DUSP4 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~43 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The A03486 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HEPG2-UV cells (catalog A03486) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A03486 · 1:1000 (catalog A03486) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
DUSP4 is predicted at 43 kDa; isoforms and modifications could affect migration, but no empirical band or visible shift is established.
| Single band near 43 kDa | consistent with the predicted size of DUSP4 |
| Several bands at different positions | could reflect isoforms 1 and 2; their migration is not established |
| Closely spaced bands near 43 kDa | could reflect phosphorylation at Ser386 or Ser391; a visible shift is not established |
| Weak band in whole-cell lysate, stronger in nuclear extract | consistent with DUSP4's nuclear localization |
| UniProt predicted mass | places the reference size near 43 kDa |
| Isoforms 1 and 2 | may differ in size, but their relative masses and migration are unspecified |
| Phosphoserine at Ser386 | may alter migration; no visible shift is established |
| Phosphoserine at Ser391 | may alter migration; no visible shift is established |
| N-acetylvaline at residue 2 | is documented, but no apparent size effect is established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | nuclear DUSP4 may be underrepresented in the sampled lysate | compare whole-cell lysate with a verified nuclear fraction |
| Band higher than expected | phosphorylation at Ser386 or Ser391 may affect migration, though a shift is unproven | compare phosphatase-treated and untreated samples and verify band identity |
| Band lower than expected | alternative splicing yields isoforms 1 and 2, whose sizes are unspecified | check band identity with an isoform-specific reference |
| Multiple bands | isoforms or phosphorylation may contribute, but distinct bands are unproven | compare isoform-specific references and phosphatase-treated samples |
| Weak or no signal | nuclear localization may limit DUSP4 in the tested fraction | test a verified nuclear extract alongside the lysate |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for DUSP4, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A03486 and A30480 are listed for human, monkey, mouse, and rat DUSP4. Both have WB images described using HEPG2-UV cells at 1:1000; A03486 specifies a nuclear extract. These captions document specific test conditions, not validation across every listed species.
Which to pick: For nuclear extracts, A03486 has the closer documented WB example. A30480 also has a HEPG2-UV WB image at 1:1000. Both list the same species reactivity, so the supplied evidence gives no broader basis to prefer one.